Trial Profile
A Phase I Clinical Study, Randomized, Single-blind,Placebo-controlled, Multiple Doses, Dose Escalation Study fo the Safety, Tolerability and Pharmacokinetics of HX-1171 in Healthy Male Subjects.
Status:
Suspended
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 10 Feb 2017
Price :
$35
*
At a glance
- Drugs HX 1171 (Primary)
- Indications Atherosclerosis; Colitis; Cutaneous lupus erythematosus; Liver disorders; Systemic lupus erythematosus
- Focus Adverse reactions; Expanded access; Pharmacokinetics
- Sponsors Biotoxtech Co
- 10 Feb 2017 New trial record